Development of fungal mycelia as a skin substitute: Characterization of keratinocyte proliferation and matrix metalloproteinase expression during improvement in the wound-healing process

Journal of Biomedical Materials Research - Part A

Volumn 72, Issue 2, 2005, Pages 220-227

  Su, Ching Hua ^a   Liu, Shu Hui ^a   Yu, Shi Yau ^a   Hsieh, Yi Ling ^a   Ho, Hsiu O ^a   Hu, Chung Hong ^b   Sheu, Ming Thau ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Fungal mycelia; Ganoderma tsugae; Keratinocyte; MMP; SACCHACHITIN; Wound healing

Indexed keywords

CELLS; ELECTROPHORESIS; FUNGI; PATIENT TREATMENT; SKIN; TISSUE;

ANIMAL MODELS; MATRIX METALLOPROTEINASES (MMP); SKIN SUBSTITUTES; WASTE RESIDUES;

BIOMEDICAL ENGINEERING;

CHITIN DERIVATIVE; GELATINASE B; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; RECOMBINANT EPIDERMAL GROWTH FACTOR; SACCHACHITIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOCOMPATIBILITY; CASE REPORT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GANODERMA; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SKIN GRAFT; SKIN ULCER; WOUND DRESSING; WOUND HEALING;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; GANODERMA; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASES; MYCELIUM; SKIN; SKIN, ARTIFICIAL; WOUND HEALING;

EID: 12444272640     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30235     Document Type: Article

References (28)

1. Martin P. Wound healing-aiming for perfect skin regeneration. Science 1997;276:75-81.
2. Clark RAF. Wound repair-overview and general considerations. In: Clark RA, editor. The molecular and cellular biology of wound repair. New York: Plenum Press; 1996: p 3-50.
3. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K. Impaired wound hearing in mice with a disrupted plasminogen gene. Nature Med 1996;2:287-292.
4. Madlener M, Parks WC, Werner S. Matrix metalloprotein (MMP) and their physiological inhibitors (TIMP) are differentially expressed during excisional skin wound repair. Exp Cell Res 1998;242:201-210.
5. Ravanti L, Kähäri VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med 2000;6:391-407.
6. Gak E, Taylor WG, Chan AM, Rubin JS. Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett 1992;311:17-21.
7. Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, Sasaguri Y, Mori Y. Degradation of interleukin 1β by matrix metalloproteinases. J Biol Chem 1996;271:14657-14660.
8. Gallea-Robache S, Morand V, Millet S, Bruneau JM, Bhatnagar N, Chouaib S, Roman-Roman S. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. Cytokine 1997;9:340-346.
9. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta I release. Biochem J 1997;322:809-814.
10. Wakita H, Furukawa F, Takigawa M. Thrombin and trypsin induce granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes. Proc Assoc Am Physicians 1997;109:190-207.
11. Grillo HC, Gross J. Collagenolytic activity during mammalian wound repair. Dev Biol 1967;15:300-317.
12. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999:274:21491-21494.
13. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Park WC. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997;137:1445-1457.
14. Park WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999;7:423-432.
15. Itoh T, Tanioka M, Yosida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998;58:1048-1051.
16. Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK, Murphy B, Ronan J, Werb Z, Banda MJ, Impaired would contraction in stromelysin-1-deficient mice. Ann Surg 1999;230:260-265.
17. Balsssa LL. Wound healing composition. GB patent 1,252,373. 1971.
18. Muzzarelli R. Methyl pyrrolidinone chitosan, production process and uses thereof. US patent 5,378,472. 1995.
19. Balsssa LL, Process for facilitating wound healing with N-acetylated partially depolymerized chitin materials. US patent 3,914,413. 1975.
20. Widra A. Hydrophilic biopolymeric copolyelectrolytes and biodegradable wound dressings comprising same. European patent 0,89,152. 1983.
21. Yano H, Iriyama K, Nishiwaki H, Kifune K. Effects of N-acetyl-D- glucosamine on wound healing in rats. Mie Med J 1985;35:53-56.
22. Malette WG. Method of achieving hemostasis inhibiting fibroplasias and promoting tissue regeneration in a tissue wound. US patent 4,532,134. 1985.
23. Su CH, Sun CS, Juan SW, Hu CH, Ke WT, Sheu MT. Fungal mycelia as the source of chitin and polysaccharides and their applications as skin substitute. Biomaterials 1997;18:1169-1174.
24. Su CH, Sun CS, Juan SW, Hu CH, Sheu MT. Development of fungal mycelia as skin substitutes II: effects on the wound healing process. N Taipei J Med 1999;1:31-39.
25. Prudden JF, Migel P, Hanson P, Friedrich L, Balassa L. The discovery of a potent pure chemical wound-healing accelerator. Am J Surg 1970;119:560-564.
26. Yager DR, Zhang LY, Liang HX, Diegelmann RF. Cohen IK. Wound fluid from human pressure ulcers contains elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107:743-748.
27. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-1102.
28. Bode W, Fernandez-Catalan C, Tschesche H, Grams F, Nagase H, Maskos K. Structural properties of matrix metalloproteinases. Cell Mol Life Sci 1999;55:639-652.